CCDC126 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.57853999999125E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.46680000000055E-05 |
Normal-vs-Stage2 |
1.189010E-04 |
Normal-vs-Stage3 |
4.1454999999968E-05 |
Normal-vs-Stage4 |
4.076200E-02 |
Stage1-vs-Stage2 |
8.418400E-01 |
Stage1-vs-Stage3 |
9.059200E-01 |
Stage1-vs-Stage4 |
4.335800E-01 |
Stage2-vs-Stage3 |
9.153000E-01 |
Stage2-vs-Stage4 |
3.189000E-01 |
Stage3-vs-Stage4 |
3.310400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.00870000042353E-07 |
Normal-vs-AfricanAmerican |
1.998350E-03 |
Normal-vs-Asian |
3.541000E-01 |
Caucasian-vs-AfricanAmerican |
1.799620E-01 |
Caucasian-vs-Asian |
1.842390E-01 |
AfricanAmerican-vs-Asian |
4.648200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.23999999993119E-07 |
Normal-vs-Female |
1.439980E-02 |
Male-vs-Female |
2.620300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.366600E-04 |
Normal-vs-Extreme_Weight |
2.05769999999106E-05 |
Normal-vs-Obese |
3.56289999999815E-05 |
Normal-vs-Extreme_Obese |
2.263900E-03 |
Normal_Weight-vs-Extreme_Weight |
5.978400E-01 |
Normal_Weight-vs-Obese |
8.567400E-01 |
Normal_Weight-vs-Extreme_Obese |
6.253600E-01 |
Extreme_Weight-vs-Obese |
3.993400E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.308800E-01 |
Obese-vs-Extreme_Obese |
4.700200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.221200E-03 |
Normal-vs-Age(41-60Yrs) |
6.354400E-04 |
Normal-vs-Age(61-80Yrs) |
1.95569999972278E-07 |
Normal-vs-Age(81-100Yrs) |
1.299930E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.361800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.440000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.328200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.330100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.233400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.814600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.975870E-04 |
Normal-VS-Type2 PRCC |
2.2231999574629E-09 |
Normal-VS-KIRP CIMP |
2.139000E-01 |
Normal-VS-Unclassified PRCC |
7.790500E-04 |
Type1 PRCC-VS-Type2 PRCC |
1.164460E-03 |
Type1 PRCC-VS-KIRP CIMP |
2.475200E-01 |
Type1 PRCC-VS-Unclassified PRCC |
6.605600E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.940700E-03 |
Type2 PRCC-VS-Unclassified PRCC |
5.630100E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.906600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.00519997775694E-09 |
Normal-vs-N1 |
1.397180E-03 |
Normal-vs-N2 |
3.376500E-02 |
N0-vs-N1 |
2.398400E-02 |
N0-vs-N2 |
6.414800E-01 |
N1-vs-N2 |
5.663000E-01 |
|
|